These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer. Hanprasertpong J, Jiamset I, Geater A, Leetanaporn K, Peerawong T. J Gynecol Oncol; 2017 Jul; 28(4):e42. PubMed ID: 28541633 [Abstract] [Full Text] [Related]
10. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Lee SP, Hong JH. Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):420-7. PubMed ID: 22365621 [Abstract] [Full Text] [Related]
11. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, Ramirez PT. Gynecol Oncol; 2007 Dec 01; 107(3):458-63. PubMed ID: 17854872 [Abstract] [Full Text] [Related]
12. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer. Cusimano MC, Baxter NN, Gien LT, Moineddin R, Liu N, Dossa F, Willows K, Ferguson SE. Am J Obstet Gynecol; 2019 Dec 01; 221(6):619.e1-619.e24. PubMed ID: 31288006 [Abstract] [Full Text] [Related]
13. Significance of perivascular lymphocytic infiltrates on survival of patients with invasive cervical cancer. Yamazawa K, Matsui H, Ishikura H, Seki K, Mitsuhashi A, Sekiya S. J Immunother; 2003 Dec 01; 26(2):149-55. PubMed ID: 12616106 [Abstract] [Full Text] [Related]
15. The prognostic impact of histological type on clinical outcomes of early-stage cervical cancer patients whom have been treated with radical surgery. Chandeying N, Hanprasertpong J. J Obstet Gynaecol; 2017 Apr 01; 37(3):347-354. PubMed ID: 28141947 [Abstract] [Full Text] [Related]
16. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery. Bean LM, Ward KK, Plaxe SC, McHale MT. Am J Obstet Gynecol; 2017 Sep 01; 217(3):332.e1-332.e6. PubMed ID: 28522318 [Abstract] [Full Text] [Related]
18. Association between prognostic factors and disease-free survival of cervical cancer stage IB1 patients undergoing radical hysterectomy. Chittithaworn S, Hanprasertpong J, Tungsinmunkong K, Geater A. Asian Pac J Cancer Prev; 2007 Sep 01; 8(4):530-4. PubMed ID: 18260723 [Abstract] [Full Text] [Related]
19. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10). Noh JM, Park W, Kim YS, Kim JY, Kim HJ, Kim J, Kim JH, Yoon MS, Choi JH, Yoon WS, Kim JY, Huh SJ. Gynecol Oncol; 2014 Mar 01; 132(3):618-23. PubMed ID: 24486605 [Abstract] [Full Text] [Related]
20. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy. Mabuchi S, Okazawa M, Kinose Y, Matsuo K, Fujiwara M, Suzuki O, Morii E, Kamiura S, Ogawa K, Kimura T. Int J Gynecol Cancer; 2012 Oct 01; 22(8):1389-97. PubMed ID: 22976497 [Abstract] [Full Text] [Related] Page: [Next] [New Search]